Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 公司是集农兽药原料药及制剂的研发、生产和销售于一体的现代化集团企业,在研产销全业务链发力以确保产品品质服务三农,坚守技术创新是核心驱动力,持续投入研发增强发展后劲,加快推进数字化转型促进智能制造步伐,通过高品质产品和高效能服务促进“精于生物科技,创造品质生活”的使命落地,服务更广大的用户。公司旗下五家生产型子公司均为高新技术企业与国家级/省级绿色工厂,产品覆盖130多个国家和地区。经过多年发展,公司已成为国际领先的绿色生物、化学合成农兽药原药、制剂生产制造服务商。公司主要从事农药、兽药原药、制剂的研发、生产和销售。产品包括农用杀菌剂、杀虫剂、除草剂以及兽药驱虫、治疗呼吸道、肠道疾病及饲料添加剂产品。 | ||||||||||||||||||||||||
Main Business | 主要从事农药、兽药原药、制剂的研发、生产和销售。 | ||||||||||||||||||||||||
Legal Representative | 李新生 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 吴昊 | ||||||||||||||||||||||||
Solicitors | 北京市中伦律师事务所 | ||||||||||||||||||||||||
Auditors | 瑞华会计师事务所(特殊普通合伙);信永中和会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0516-88984524;0516-88984525 | ||||||||||||||||||||||||
Fax No | 0516-88984525 | ||||||||||||||||||||||||
Website | www.chinalimin.com | ||||||||||||||||||||||||
boardoffice@chinalimin.com;limin@chinalimin.com;linqing@chinalimin.com;liuyong@chinalimin.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 27/01/2015 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.170 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.200 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 7.083 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 2.519B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |